Replies to post #143143 on Anavex Life Sciences Corp (AVXL)

[Phoenix64]

Nice, great information for upcoming conferences. Hopefully this will turn the tide

[kevli33]

TGD on Friday March 9

4:30 pm - 6:00 pm
Emerging Therapies: Epilepsy Drugs
Chair: Steven Schachter, MD, Professor, Neurology, Harvard Medical School

Faculty
ZX008 for the treatment of Dravet Syndrome
Gail Farfel, PhD, Chief Development Officer, Zogenix

ANAVEX 2-73 as a potential treatment for Rett Syndrome and other pediatric or infantile disorders with seizure pathology
Christopher Missling, PhD, President and CEO, Anavex Life Sciences Corp


https://c.ymcdn.com/sites/asent.site-ym.com/resource/resmgr/docs/Program_Books/18_ASENT_Advance_Program.pdf